SCHEMBL16201332

SCHEMBL16201332

CCCN(C)Cc1c[nH]nc1-c1ccc(OC(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 5/20 0.51
PRMT6 Q96LA8 3/20 0.51
PRMT8 Q9NR22 3/20 0.51
PRMT3 O60678 2/20 0.51
CARM1 Q86X55 2/20 0.51
NOTUM Q6P988 1/20 0.36
BTK Q06187 2/20 0.32
MAPT P10636 1/20 0.32
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
PTPN5 P54829 1/20 0.31
KDM5A P29375 2/20 0.31
KDM4A O75164 1/20 0.31
KDM5C P41229 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
XDH P47989 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201345 0.89 PRMT3 (0.40) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201159 0.89 PRMT1 (0.65) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16194484 0.87 PRMT1 (0.50) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201446 0.86 PRMT6 (0.42) PRMT1PRMT6PRMT8PRMT3CARM1
Hydrochloric Acid SCHEMBL16194421 0.86 PRMT1 (0.49) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201414 0.86 PRMT1 (0.41) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201419 0.85 MEN1 (0.41) MAPTXDH
SCHEMBL16772920 0.83 PRMT6 (0.38) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201421 0.83 MEN1 (0.36) PRMT1PRMT6PRMT8PRMT3CARM1
SCHEMBL16201370 0.82 PRMT3 (0.33) PRMT1PRMT6PRMT8PRMT3CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776972-B2 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof EPIZYME INC. (US) 2017-10-03 US disclosed
US-9346761-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2016-05-24 US disclosed
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-05-19 US disclosed
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885PRMT6 4/4885PRMT8 6/4885
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885PRMT6 5/4885PRMT8 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.